Co-Authors
This is a "connection" page, showing publications co-authored by NICOLA HANANIA and MUHAMMAD ADRISH.
Connection Strength
6.104
-
POINT: Should Triple Inhaled Therapy Be Considered in All Patients With Group E COPD? Yes. Chest. 2024 Jul; 166(1):12-17.
Score: 0.912
-
Rebuttal From Drs Adrish and Hanania. Chest. 2024 Jul; 166(1):20-21.
Score: 0.912
-
Revisiting the Use of Antibiotics to Prevent COPD Exacerbation: Is Doxycycline the Answer? Am J Respir Crit Care Med. 2023 09 01; 208(5):509-511.
Score: 0.861
-
Asthma and cardiovascular disease: A bidirectional association? Respirology. 2023 03; 28(3):217-219.
Score: 0.828
-
Choosing and switching biological agents in severe asthma. Respirology. 2022 11; 27(11):926-928.
Score: 0.807
-
Phenotypes of Asthma-Chronic Obstructive Pulmonary Disease Overlap. Immunol Allergy Clin North Am. 2022 08; 42(3):645-655.
Score: 0.794
-
Established and Emerging Asthma Biomarkers with a Focus on Biologic Trials: A Narrative Review. J Pers Med. 2025 Aug 13; 15(8).
Score: 0.246
-
The Emerging Biomarkers in Chronic Obstructive Pulmonary Disease: A Narrative Review. Diagnostics (Basel). 2025 May 14; 15(10).
Score: 0.242
-
Personalized COPD Care: The Future of Precision-Based Therapies. J Clin Med. 2024 Oct 23; 13(21).
Score: 0.233
-
Update on the Role of FeNO in Asthma Management. Diagnostics (Basel). 2023 Apr 15; 13(8).
Score: 0.210
-
Asthma outcomes in a safety net hospital system: A comparative study to a national cohort. Respir Med. 2025 Apr-May; 240:108032.
Score: 0.060